about
Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumoursVitamin D and the mammary gland: a review on its role in normal development and breast cancerCLMP is required for intestinal development, and loss-of-function mutations cause congenital short-bowel syndromeP-cadherin and the journey to cancer metastasisP-Cadherin Linking Breast Cancer Stem Cells and Invasion: A Promising Marker to Identify an "Intermediate/Metastable" EMT StateActin stress fiber organization promotes cell stiffening and proliferation of pre-invasive breast cancer cells.Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours.Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype.CCAAT/enhancer binding protein β (C/EBPβ) isoforms as transcriptional regulators of the pro-invasive CDH3/P-cadherin gene in human breast cancer cells.CLMP is essential for intestinal development, but does not play a key role in cellular processes involved in intestinal epithelial developmentThe bacterial protein azurin impairs invasion and FAK/Src signaling in P-cadherin-overexpressing breast cancer cell models.P-cadherin expression in breast cancer: a review.Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma.P-cadherin role in normal breast development and cancer.Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypes.Epithelial E- and P-cadherins: role and clinical significance in cancer.E-cadherin dysfunction in gastric cancer--cellular consequences, clinical applications and open questions.OXPHOS dysfunction regulates integrin-β1 modifications and enhances cell motility and migration.Differential sensitivities to lactate transport inhibitors of breast cancer cell lines.Atomic force microscopy and graph analysis to study the P-cadherin/SFK mechanotransduction signalling in breast cancer cells.P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model.Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness.P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer.CPEB1, a novel gene silenced in gastric cancer: a Drosophila approach.Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation.Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells.The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin.Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management.P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma.P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells.Quantification of topological features in cell meshes to explore E-cadherin dysfunction.Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulationMonocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma.Molecular phenotypes of matched in situ and invasive components of breast carcinomas.P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ.Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer.Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types.
P50
Q21030553-11B6BD22-E889-4BCC-9CAF-7D00BE3AE7F9Q21195200-C23E8F4C-1350-473B-BE32-A40408FC4C75Q24299304-63942B7C-27BC-4BDA-ADFA-13A027CDD2ADQ26781906-1032D58B-BD60-4E46-85DC-24C3361FDCD5Q27003394-51438B0F-AE08-4C9B-A8F8-5774BDE5CDE4Q30852504-AB00A2FC-B919-43B6-9ADE-817C9A50D550Q33594249-028C84A7-FB66-4B6B-BA2D-958AA79CF82BQ33690078-76491C9C-F34B-4CE6-A4E1-87853FD0A000Q34309472-F52EA0B7-2ABB-49CA-B5E9-D891FE6D627EQ34584480-90ECC646-DF09-4803-B0B8-989B6695CC95Q34608227-B044ABE0-88E7-42BE-991E-5DFA437C27D3Q34873875-216E134D-4A15-4B77-8E84-863ECB1ADA92Q36458759-F3BED446-7C1A-49A1-ABD9-01B2B5B153A3Q37396926-EAD882F4-9F5F-4609-91FF-26939743330FQ37967582-62376202-D5F5-492D-AD9C-C7F21C0A9AF0Q38007856-C5CA4F44-DD9D-40E0-ABCA-478C733CCDD4Q38011915-55495220-5FF5-4D2C-BBB7-AA25B91BCB77Q38030236-53D13E04-BE0C-4BC1-83BC-F76D47864F92Q38928748-B74AD520-F687-4D71-8996-B02F51E5BB63Q39068526-5F20FC2B-B582-4C57-952E-FCCB9F1F3A0CQ39185024-143AD9BB-68DC-48F8-8585-0A775470F140Q39238903-A0DA5B7D-CC23-44AC-8C29-A758944A024EQ39266398-BCA91ACC-F14B-4BDC-BAF5-C6E79A24437FQ39385880-C2A58556-3EC9-4D03-8CA3-92AF4A3A3990Q39448400-A0F6E5A9-AA09-4753-B3A5-B63F3D712D30Q39523158-B8784E94-20FE-4445-B0F0-3A80B9BDFFC4Q39715731-EF01EBD2-1D55-466B-8BFF-4444E06A7B53Q39776935-4919CE2A-9320-4670-9D7A-F32A5F08CF5DQ39858836-2A7E5E95-BDA6-4161-B996-0591BF8A63EAQ40145680-ADB4E43E-AF97-4A07-A2B5-5373769BED5FQ40365844-07BBFC13-5ACB-4B58-B2F0-DC57B0155AB9Q40382338-F42792CE-9420-4C04-A9B8-53ABC0E781B5Q40490659-D5DFD6C8-8B2C-4091-9EEF-BAAA9B9CF8B4Q41085527-B9B6D61F-222B-425A-9FC7-BB88580B548CQ41382123-BA8911BE-FCC3-41DC-AB66-D3CD151C27D3Q42474425-D921C9A1-869C-429A-8BA8-910D2E626841Q42486032-FF618ACF-A682-4437-B3D2-F58A60892E35Q42504546-F900D291-AD8D-4448-A979-043EBB64D918Q42508067-2A37CA5E-0B39-4459-B64E-426ECE987DAAQ42515110-CD36FB3A-7DC2-4406-A88E-3A13E03E7EF1
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Joana Paredes
@ast
Joana Paredes
@en
Joana Paredes
@es
Joana Paredes
@nl
Joana Paredes
@sl
type
label
Joana Paredes
@ast
Joana Paredes
@en
Joana Paredes
@es
Joana Paredes
@nl
Joana Paredes
@sl
altLabel
Joana Paredes
@en
prefLabel
Joana Paredes
@ast
Joana Paredes
@en
Joana Paredes
@es
Joana Paredes
@nl
Joana Paredes
@sl
P214
P1053
F-8224-2011
P106
P1153
7004818525
P21
P214
P31
P3829
P496
0000-0002-1076-1343
P734
P735
P7859
viaf-98989730